These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18815363)

  • 21. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
    Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
    Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of the chemokine receptor, CCR5.
    Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
    Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.
    Alvarez Arias D; Navenot JM; Zhang WB; Broach J; Peiper SC
    J Biol Chem; 2003 Sep; 278(38):36513-21. PubMed ID: 12837756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans.
    Reis Rodrigues P; Kaul TK; Ho JH; Lucanic M; Burkewitz K; Mair WB; Held JM; Bohn LM; Gill MS
    G3 (Bethesda); 2016 Jun; 6(6):1695-705. PubMed ID: 27172180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G protein subtype-specific signaling bias in a series of CCR5 chemokine analogs.
    Lorenzen E; Ceraudo E; Berchiche YA; Rico CA; Fürstenberg A; Sakmar TP; Huber T
    Sci Signal; 2018 Oct; 11(552):. PubMed ID: 30327411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha.
    Raport CJ; Gosling J; Schweickart VL; Gray PW; Charo IF
    J Biol Chem; 1996 Jul; 271(29):17161-6. PubMed ID: 8663314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of EGL-47, a Galpha(o)-coupled receptor, inhibits function of hermaphrodite-specific motor neurons to regulate Caenorhabditis elegans egg-laying behavior.
    Moresco JJ; Koelle MR
    J Neurosci; 2004 Sep; 24(39):8522-30. PubMed ID: 15456826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).
    Karlshøj S; Amarandi RM; Larsen O; Daugvilaite V; Steen A; Brvar M; Pui A; Frimurer TM; Ulven T; Rosenkilde MM
    J Biol Chem; 2016 Dec; 291(52):26860-26874. PubMed ID: 27834679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential tradeoff between feeding rate and aversive learning determines intoxication in a Caenorhabditis elegans host-pathogen system.
    Velagapudi P; Ghoubrial R; Shah R; Ghali H; Haas M; Patel KS; Riddell A; Blanar CA; Smith RP
    Microbes Infect; 2020 Sep; 22(8):340-348. PubMed ID: 32014589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3.
    Govaerts C; Bondue A; Springael JY; Olivella M; Deupi X; Le Poul E; Wodak SJ; Parmentier M; Pardo L; Blanpain C
    J Biol Chem; 2003 Jan; 278(3):1892-903. PubMed ID: 12411445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking.
    Arumugam K; Crouzy S; Chevigne A; Seguin-Devaux C; Schmit JC
    J Biomol Struct Dyn; 2014; 32(8):1274-89. PubMed ID: 23869548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular cloning and functional expression of the dog CCR5.
    Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
    Louboutin JP; Strayer DS
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [MMP-9 expression profile in inflammatory cells of Mip-1alpha knockout mice and Mip-1alpha receptor knockout mice].
    Wu Y; Mukaida N; Liu T; Jia YQ; Zhu HL; Yang YM; Xu CG; Hu ZX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):374-7. PubMed ID: 19626984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
    Balashov KE; Rottman JB; Weiner HL; Hancock WW
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
    Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
    J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.